Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Daylight as Adjunctive Treatment in Patients With Depression

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Fulfilling criteria for an ICD-10 diagnosis of unipolar depression (F. 32.0, F.32.1, F.32.2, F32.3, F. 32.8. F.33.0, F.33.1, F.33.2, F. 33.3)~* Hamilton Depression Score (HAM-D17) ≥ 12~* In treatment with the same antidepressant medication 14 days prior to inclusion~* The participant must have access to a smart phone~Exclusion Criteria:~* Actual treatment with Electro Convulsive Therapy (ECT)~* Seasonal Affective Disorder (SAD)~* Known sleep disturbances (sleep-apnoea, narcolepsy, or restless legs syndrome)~* On lithium, agomelatine, melatonin and/or mirtazapine~* Known eye disorders~* Current alcohol- or drug abuse~* Current user of Light therapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Group 1 (intervention group) (Type: EXPERIMENTAL): Regular exposure to morning daylight
- Group 2 (control group) (Type: NO_INTERVENTION): Treatment as usual.

Based on this trial design, predict the completion outcome and termination type (if applicable).